Evidence map›Paper›PMID 27161480›Full record

ArticleBMC genomics2016

High-throughput cis-regulatory element discovery in the vector mosquito Aedes aegypti.

Susanta K Behura, Joseph Sarro, Ping Li, Keshava Mysore, David W Severson, Scott J Emrich, Molly Duman-Scheel

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Altered histone modifications inbioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Review
  5. The regulatory genome of the malaria vectorNAR genomics and bioinformatics · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Susanta K BehuraEck Institute for Global Health, University of Notre Dame, Notre Dame, IN, 46556, USA.
Joseph SarroEck Institute for Global Health, University of Notre Dame, Notre Dame, IN, 46556, USA.
Ping LiEck Institute for Global Health, University of Notre Dame, Notre Dame, IN, 46556, USA.
Keshava MysoreEck Institute for Global Health, University of Notre Dame, Notre Dame, IN, 46556, USA.
David W SeversonEck Institute for Global Health, University of Notre Dame, Notre Dame, IN, 46556, USA.
Scott J EmrichEck Institute for Global Health, University of Notre Dame, Notre Dame, IN, 46556, USA. semrich@nd.edu.
Molly Duman-ScheelEck Institute for Global Health, University of Notre Dame, Notre Dame, IN, 46556, USA. mscheel@nd.edu.
University of Notre Dame · US

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Cis-regulatory element discovery in a sequenced mosquito genomeR21AI117145 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI SCHEEL, MOLLY DUMAN · 2015 to 2016
$429k
NCATS NIH HHS UL1 TR001108NIAID NIH HHS R21 AI117145
6 · The paper itself

Abstract

backgroundDespite substantial progress in mosquito genomic and genetic research, few cis-regulatory elements (CREs), DNA sequences that control gene expression, have been identified in mosquitoes or other non-model insects. Formaldehyde-assisted isolation of regulatory elements paired with DNA sequencing, FAIRE-seq, is emerging as a powerful new high-throughput tool for global CRE discovery. FAIRE results in the preferential recovery of open chromatin DNA fragments that are not bound by nucleosomes, an evolutionarily conserved indicator of regulatory activity, which are then sequenced. Despite the power of the approach, FAIRE-seq has not yet been applied to the study of non-model insects. In this investigation, we utilized FAIRE-seq to profile open chromatin and identify likely regulatory elements throughout the genome of the human disease vector mosquito Aedes aegypti. We then assessed genetic variation in the regulatory elements of dengue virus susceptible (Moyo-S) and refractory (Moyo-R) mosquito strains.

resultsAnalysis of sequence data obtained through next generation sequencing of FAIRE DNA isolated from A. aegypti embryos revealed >121,000 FAIRE peaks (FPs), many of which clustered in the 1 kb 5' upstream flanking regions of genes known to be expressed at this stage. As expected, known transcription factor consensus binding sites were enriched in the FPs, and of these FoxA1, Hunchback, Gfi, Klf4, MYB/ph3 and Sox9 are most predominant. All of the elements tested in vivo were confirmed to drive gene expression in transgenic Drosophila reporter assays. Of the >13,000 single nucleotide polymorphisms (SNPs) recently identified in dengue virus-susceptible and refractory mosquito strains, 3365 were found to map to FPs.

conclusionFAIRE-seq analysis of open chromatin in A. aegypti permitted genome-wide discovery of CREs. The results of this investigation indicate that FAIRE-seq is a powerful tool for identification of regulatory DNA in the genomes of non-model organisms, including human disease vector mosquitoes.

Indexed as

High-Throughput Nucleotide SequencingRegulatory Sequences, Nucleic AcidAedesAnimalsBinding SitesChromosome MappingGene ExpressionGenes, ReporterGenetic VariationGenome, InsectGenomicsInsect VectorsKruppel-Like Factor 4Transcription FactorsUntranslated RegionsKLF4 protein, humanKruppel-Like Factor 4Transcription FactorsUntranslated RegionsDengue virusDrosophilaFAIRE-seqGenomeNext generation sequencingZika

Identifiers

PMID27161480
PMCPMC4862039
OpenAlexW2346511773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.